Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268079 synergistically reduces dark melanin production
10/30/2008US20080268078 Composition for inhibiting nitric oxide and/or prostaglandin E2 synthesis and method for inhibiting inflammation
10/30/2008US20080268077 Process for Strengthening the Barrier Function of Undamaged Skin
10/30/2008US20080268076 retrofractamide A, pipercide, piperrolein B, piperchabamide D, pellitorin or combinations thereof; preventing and treating vascular diseases, such as hyperlipidemia, arteriosclerosis, etc.
10/30/2008US20080268075 mixture of Garcinia extract, Green tea extract, Green coffee extract and Banaba extract; reducing weight, and treating diabetes
10/30/2008US20080268073 derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, Rutaceae, Laminariaceae, Myrtaceae and Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor
10/30/2008US20080268071 NMDA receptor modulators
10/30/2008US20080268067 inhibiting a Cav3 calcium channel in a cell using a C2-C10 alkyl alcohol;
10/30/2008US20080268066 Synergistic Formulation for Preventing and/or Treating Diabetes
10/30/2008US20080268063 Coated Controlled Release Polymer Particles as Efficient Oral Delivery Vehicles for Biopharmaceuticals
10/30/2008US20080268061 injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer; release of the therapeutically active substances is caused, initiated or substantially enhanced by an alternating magnetic field
10/30/2008US20080268060 passing a liquid nanoscale particle precursor material through a flow passage heated to convert the carrier into a vapor and the second component into nanoscale particles; can be incorporated in a hand held inhaler, and can be delivered to a targeted portion of the lung using the inhaler
10/30/2008US20080268057 Controlled release carvedilol compositions
10/30/2008US20080268053 Collagen carrier of therapeutic genetic material, and method
10/30/2008US20080268051 Anti-angiogenesis; viscosity inducing component is injectable into the vitreous of a mammalian eye without permanently diminishing visual acuity
10/30/2008US20080268050 Sprayable topical skin barriers
10/30/2008US20080268049 having reduced levels of 3-ethyl methyl [(2-aminoethoxy)methyl](2-chlorophenyl)methylpyridine-3,5 dicarboxylate ("impurity D") and total impurities when free of dicalcium phosphate
10/30/2008US20080268048 Pharmaceutical composition for contraception and for reducing the risk of congenital abnormalities
10/30/2008US20080268046 For phosphodiesterase inhibitor vardenafil
10/30/2008US20080268045 Sustained release methotrexate formulations and methods of use thereof
10/30/2008US20080268044 Novel Process and Formulations
10/30/2008US20080268043 Controlled Release Compositions Comprising an Antipsychotic Agent
10/30/2008US20080268042 Omega 3 fatty acid formulations
10/30/2008US20080268041 Composition of 11 beta -(4-acetylphenyl)-17 beta -hydroxy-17 alpha -(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one and Tamoxifen; inhibits growth of breast cells
10/30/2008US20080268040 Organic Compounds Comprising a Glycopyrrolium Salt
10/30/2008US20080268038 Composition of essential amino acids L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-valine and L-threonine
10/30/2008US20080268036 Co-processing of active pharmaceutical/nutraceutical ingredients
10/30/2008US20080268035 Cationic Polymer Nanoparticles Encapsulating An Active Ingredients, And The Cosmetic Composition Containing The Same
10/30/2008US20080268034 High surface area of colloidal silicon dioxide neutralizes the surface charges from the particles which then de-segregate into individual particles, with colloidal silicon dioxide acting as a drug carrier; easily processed into a desired dosage form
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268030 Gene therapy for diabetic ischemic disease
10/30/2008US20080268025 Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use
10/30/2008US20080268024 Compositions for Oral and/or Topical Administration
10/30/2008US20080268023 Sufentanil and a bioadhesive material, for sublingual administration
10/30/2008US20080268022 Mehtods for treating and preventing ailments caused by human papillomavirus
10/30/2008US20080268021 Adhesive bioerodible ocular drug delivery system
10/30/2008US20080268020 Ophthalmic Emulsions Containing Prostaglandins
10/30/2008US20080268014 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation
10/30/2008US20080268013 Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons
10/30/2008US20080268010 Inhibiting growth of bacteria on implantable medical devices
10/30/2008US20080268007 Beauty/medication patch
10/30/2008US20080268004 Stable Water-In-Oil-In-Water Multiple Emulsion System Produced By Hydrodynamic Dual Stabilization And A Method For Preparation Thereof
10/30/2008US20080267996 Compositions for inducing an immune response against hepatitis B
10/30/2008US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy
10/30/2008US20080267977 Combined immunological agent and sensitizing agent for the treatment of cancer
10/30/2008US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases
10/30/2008US20080267970 Sulfonamide Derivatives For The Treatment of Diseases
10/30/2008US20080267969 Treatment of Pulmonary Hypertension Using an Agent That Inhibits a Tissue Factor Pathway
10/30/2008US20080267968 Using cocktail comprising endothelial growth factor specific immunoglobulin and chemotherapeutic agent to treat and/or prevent cervical cancer
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae
10/30/2008US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER
10/30/2008US20080267957 Combination cancer therapy
10/30/2008US20080267956 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
10/30/2008US20080267951 Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling
10/30/2008US20080267950 Molecular determinants of myeloma bone disease and uses thereof
10/30/2008US20080267947 Stabilizes, reduces or eliminates cancer stem cells
10/30/2008US20080267945 Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents
10/30/2008US20080267942 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality
10/30/2008US20080267941 Nutrition Comprising Betaine Against Muscle Wasting
10/30/2008US20080267939 Plant extract for use in treatment and prevention of hypertensive disorders
10/30/2008US20080267938 Cardiac phyto-nutraceutical synergistic composition
10/30/2008US20080267935 Using mixture comprising cytosine arabinoside (AraC) and granulocyte macrophage colony stimulating factor immunotherapeutic to treat cell proliferative disorders; antitumor agents
10/30/2008US20080267931 Compositions for Silencing the Expression of Vdac1 and Uses Thereof
10/30/2008US20080267924 Repairing tissue and reducing localized fluid retention after surgery via exposure to vascular endothelial growth factors before, during and after surgery; tissue repair
10/30/2008US20080267918 Serine protease inhibitors; replication inhibition
10/30/2008US20080267915 Hcv Ns3-Ns4a Protease Inhibition
10/30/2008US20080267914 Chemical Compounds
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/30/2008US20080267909 Using acetyl-low density lipoprotein (acetyl-LDL) and an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor as stimulatory tools in identifying modulators which treat and/prevent heart, cardiovascular and diabetic disorders
10/30/2008US20080267908 Using alteration in interleukin-32 binding to proteinase-3 to identify compounds which maybe useful in treatment of inflammatory disorders
10/30/2008US20080267906 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity
10/30/2008US20080267905 Antiinflammatory; angiogenesis inhibitors; synergistic; kits
10/30/2008US20080267903 Cationic polyamines and dendrimeric polymers; anti-proliferative agents; for treatment of neoplasms and tumours, inflammatory disorders, autoimmune disorders, psoriasis, and atherosclerosis; gene therapy
10/30/2008US20080267902 Blood products with binding agent
10/30/2008US20080267901 Biocompatible Polymer Networks
10/30/2008US20080267896 Continuous liquid fatty phase; non-silicone oils; for application to skin, hair
10/30/2008US20080267890 Anti-Microbial Agent
10/30/2008US20080267889 Cosmetic Cooling Composition
10/30/2008US20080267888 Heterocyclic Derivatives
10/30/2008US20080267887 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits
10/30/2008US20080267886 Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
10/30/2008US20080267879 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
10/30/2008US20080267873 Aqueous injection buffer containing sodium chloride, calcium chloride, potassium chloride in the preparation of a RNA injection solution for increasing RNA transfer, RNA translation in a host organism
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267870 1-[(2'-Substituted)-piperazin-1' -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008US20080267866 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/30/2008US20080267862 Method of treating cancer
10/30/2008US20080267861 Myocardial Perfusion Imaging
10/30/2008DE102007020554A1 Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes Nucleic acid-containing cosmetic and / or pharmaceutical preparations for the treatment of epithelial integument
10/30/2008DE102007019691A1 Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie Use of substituted acyclic Furopyrimidin derivatives for the treatment of pulmonary arterial hypertension
10/30/2008DE102007019690A1 Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie Using cyclic substituents Furopyrimidin derivatives for the treatment of pulmonary arterial hypertension
10/30/2008DE102007019071A1 Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin A stabilized pharmaceutical composition containing pregabalin
10/30/2008CA2721855A1 Thermal-responsive polymer siloxanes, compositions, and methods and applications related thereto
10/30/2008CA2721770A1 Medical use of conjugated polyelectrolytes
10/30/2008CA2721739A1 Drug combination and its use in the treatment of muscle loss
10/30/2008CA2721320A1 Boron-containing compounds, uses and preparation thereof
1 ... 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 ... 7860